Solaris Pharma Corporation located in Bridgewater, New Jersey is pleased to announce the launch of Clindamycin Phosphate Gel USP, 1% supplied in 30 g and 60 g tubes. For additional information, please visit the products page or email us directly at info@solaris-pharma.com
News &
Events
Updated: June 2, 2026
Solaris Pharma Announces Launch of Clindamycin Phosphate Gel USP, 1% in 30 g and 60 g Tubes
About Solaris
Solaris Pharma Corporation, A Privately Held Company Headquartered In Bridgewater, NJ, Is A Specialty Pharmaceutical Company Developing And Commercializing High Value Drug Products With Limited Generic Competitors. Solaris Is Committed To Development Of Complex Dosage Forms And 505(B)(2) Products That Bring Value To Patients By Providing Access To Quality, Affordable Medicine.
Contact
Shalin Jani
CEO
Info@Solaris-Pharma.com
Source: Solaris Pharma Corporation
Press Release
